首页> 外文期刊>Peptides: An International Journal >Does increased endogenous CCK interact with serotonin to reduce food intake in rats?
【24h】

Does increased endogenous CCK interact with serotonin to reduce food intake in rats?

机译:增加的内源性CCK是否与血清素相互作用以减少大鼠的食物摄入?

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was aimed to test the hypothesis that increased endogenous CCK may interact with the anorectic serotonergic agent dl-fenfluramine to reduce food intake in rats. Previous studies, using selective CCK receptor antagonists, could demonstrate CCK-dependent 5-HT-induced anorexia. In the present approach, we used protease inhibitors to increase levels of endogenous CCK instead of blocking CCK receptors by antagonists. The protease inhibitors we used were soybean trypsin inhibitor (STI) and camostate. We hypothesized that combining the anorectic serotonergic drug dl-fenfluramine with either STI or camostate should result in an enhanced hypophagic effect when compared to single drug treatment. All feeding experiments were performed in non-deprived rats during night time feeding. Given alone, STI (500 mg/kg, po), camostate (200 mg/kg po) and also fenfluramine (1-9 mg/kg ip) reduced significantly food intake, with a more pronounced effect following fenfluramine. However, the experiments do not provide evidence for any additive or synergistic action between camostate or STI and the anorectic serotonergic drug dl-fenfluramine on food intake.
机译:本研究旨在检验以下假说:内源性CCK增加可能与厌食性5-羟色胺能药dl-芬氟拉明相互作用,从而减少大鼠的食物摄入。以前的研究,使用选择性CCK受体拮抗剂,可以证明CCK依赖性5-HT引起的厌食症。在本方法中,我们使用蛋白酶抑制剂来增加内源性CCK的水平,而不是通过拮抗剂阻断CCK受体。我们使用的蛋白酶抑制剂是大豆胰蛋白酶抑制剂(STI)和迷彩剂。我们假设与单药治疗相比,将厌食性5-羟色胺能药物dl-芬氟拉明与STI或迷彩剂合用会导致增强的吞咽作用。所有喂食实验均在夜间喂食的非剥夺大鼠中进行。单独服用STI(500 mg / kg,口服),迷迭香(200 mg / kg口服)以及fenfluramine(1-9 mg / kg ip ip)可以显着降低食物摄入量,fenfenramine服用后效果更明显。但是,该实验没有提供证据证明迷彩或STI与厌食性5-羟色胺能药物dl-芬氟拉明对食物摄入有任何累加或协同作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号